Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Oct;19(5):466-70.
doi: 10.1097/00004714-199910000-00011.

Limited efficacy of ketoconazole in treatment-refractory major depression

R T Malison  1 , A Anand, G H Pelton, P Kirwin, L Carpenter, C J McDougle, G R Heninger, L H Price
Affiliations
Clinical Trial

Limited efficacy of ketoconazole in treatment-refractory major depression

R T Malison et al. J Clin Psychopharmacol. 1999 Oct.

Abstract

The authors examined the efficacy of ketoconazole in 16 adults with treatment-refractory major depressive disorder. Subjects participated in a 6-week, double-blind, placebo-controlled trial. Assessments of mood were made using the Hamilton Rating Scale for Depression (HAM-D), the Beck Depression Inventory (BDI), and the Clinical Global Impression Scale (CGI). Results showed that none of eight patients randomly assigned to receive placebo and two of eight patients randomly assigned to receive ketoconazole met criteria for response. As a group, patients assigned to receive ketoconazole showed no significant reductions in HAM-D, BDI, or CGI scores during the 6-week trial compared with those receiving placebo. These findings suggest a limited efficacy for ketoconazole in patients with treatment-refractory major depression.

PubMed Disclaimer

Publication types